SCHEMBL9997441

SCHEMBL9997441

O=C(O)C1C=CC=CC1(O)NS(=O)(=O)c1cc(Br)c(Cl)s1

nearest known ligand 0.39

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 1/20 0.39
EGFR P00533 1/20 0.33
RAD51 Q06609 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9997961 0.72 RECQL (0.36)
SCHEMBL9997010 0.70 EDNRB (0.37)
SCHEMBL9996879 0.68 KMT2A (0.41)
SCHEMBL9997385 0.68 POLB (0.41)
SCHEMBL9997338 0.68 MEP1B (0.47)
SCHEMBL9997179 0.68 PTK2B (0.34)
SCHEMBL9997382 0.66 CA12 (0.44)
SCHEMBL9997302 0.65 KAT6A (0.42)
SCHEMBL1510259 0.64 FBP1 (0.48) FBP1EGFRRAD51
SCHEMBL21857831 0.64 GAA (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011161201-A1 BISARYLSULFONAMIDES USEFUL AS KINASE INHIBITORS IN THE TREATMENT OF INFLAMMATION AND CANCER KANCERA AB (SE) 2011-12-29 WO disclosed